Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Future Microbiol. 2008;3(6):649-660.

Novel CDSCO and US FDA approved pneumonia drugs to ease public health challenge: Nandita Vijayasimha., Bengaluru Friday, December 13, 2024, 08:00 Hrs [IST] Indian healthcare provi ...

一、当前CRO感染耐药形势及“三剑客”治疗面临的不足碳青霉烯耐药革兰阴性杆菌（CRO）包括碳青霉烯类耐药肠杆菌目细菌（CRE）、碳青霉烯类耐药铜绿假单胞菌（CRPA）和碳青霉烯类耐药鲍曼不动杆菌（CRAB），覆盖范围非常广，是重大的公共卫生“威胁”， ...

Their analysis shows that children's risk of developing asthma ... Combination Treatment Improves Response to Immunotherapy for Lung Cancer Sep. 25, 2024 — Researchers have tested a combination ...

Dec. 11, 2024 — Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID-19 and Ebola -- while also minimizing side effects ...

When bacteria enter the bloodstream (bacteremia), they can cause severe infection leading to sepsis (the body's extreme ...

Across India, at least 30 critically ill patients infected with multidrug-resistant (MDR) or extreme drug-resistant (XDR) bacteria that don’t respond to even last-line antibiotics — also called superb ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...